Separating generalized anxiety disorder from major depression using clinical, hormonal, and structural MRI data: A multimodal machine learning study

Generalized anxiety disorder (GAD) is difficult to recognize and hard to separate from major depression (MD) in clinical settings. Biomarkers might support diagnostic decisions. This study used machine learning on multimodal biobehavioral data from a sample of GAD, MD and healthy subjects to differentiate subjects with a disorder from healthy subjects (case‐classification) and to differentiate GAD from MD (disorder‐classification).

[1]  Peter A. Bandettini,et al.  Does feature selection improve classification accuracy? Impact of sample size and feature selection on classification using anatomical magnetic resonance images , 2012, NeuroImage.

[2]  D. Carroll,et al.  Major depressive disorder, generalised anxiety disorder, and their comorbidity: Associations with cortisol in the Vietnam Experience Study , 2011, Psychoneuroendocrinology.

[3]  A. Villringer,et al.  Mapping the depressed brain: a meta-analysis of structural and functional alterations in major depressive disorder. , 2012, Journal of affective disorders.

[4]  A. Hofman,et al.  Anxiety disorders and salivary cortisol levels in older adults: a population-based study , 2013, Psychoneuroendocrinology.

[5]  M. Craske,et al.  A dimensional approach to measuring anxiety for DSM‐5 , 2012, International journal of methods in psychiatric research.

[6]  K. Dedovic,et al.  The cortisol awakening response and major depression: examining the evidence , 2015, Neuropsychiatric disease and treatment.

[7]  Tilo Kircher,et al.  Predicting treatment response to cognitive behavioral therapy in panic disorder with agoraphobia by integrating local neural information. , 2015, JAMA psychiatry.

[8]  T J Meyer,et al.  Development and validation of the Penn State Worry Questionnaire. , 1990, Behaviour research and therapy.

[9]  B. Franke,et al.  From estimating activation locality to predicting disorder: A review of pattern recognition for neuroimaging-based psychiatric diagnostics , 2015, Neuroscience & Biobehavioral Reviews.

[10]  G. Andrews,et al.  DSM-IV generalized anxiety disorder in the Australian National Survey of Mental Health and Well-Being , 2002, Psychological Medicine.

[11]  D. Steffens,et al.  Diffusion tensor imaging studies in late‐life depression: systematic review and meta‐analysis , 2014, International journal of geriatric psychiatry.

[12]  Cecilia A. Essau,et al.  DIA-X-Interview , 1999 .

[13]  S. Ulrike,et al.  Major depression in young girls is related to altered cortisol awakening response , 2013, European Child & Adolescent Psychiatry.

[14]  Hongshik Ahn,et al.  A weight-adjusted voting algorithm for ensembles of classifiers , 2011 .

[15]  K. Tansey,et al.  Biomarkers predicting treatment outcome in depression: what is clinically significant? , 2012, Pharmacogenomics.

[16]  Rachel M. Brouwer,et al.  Can structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjects , 2014, NeuroImage.

[17]  Klaus P. Ebmeier,et al.  Multi-centre diagnostic classification of individual structural neuroimaging scans from patients with major depressive disorder. , 2012, Brain : a journal of neurology.

[18]  R. Carleton,et al.  Increasingly certain about uncertainty: Intolerance of uncertainty across anxiety and depression. , 2012, Journal of anxiety disorders.

[19]  Andrea Mechelli,et al.  Voxelwise meta-analysis of gray matter reduction in major depressive disorder , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[20]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[21]  D. Pine,et al.  Gray and white matter volume abnormalities in generalized anxiety disorder by categorical and dimensional characterization , 2015, Psychiatry Research: Neuroimaging.

[22]  M. Höfler,et al.  Generalized anxiety and depression in primary care: prevalence, recognition, and management. , 2002, The Journal of clinical psychiatry.

[23]  V. Starcevic CASE HISTORIES AND SHORTER COMMUNICATIONS Pathological worry in major depression: a preliminary report , 1995 .

[24]  R. Carleton,et al.  Fearing the unknown: a short version of the Intolerance of Uncertainty Scale. , 2007, Journal of anxiety disorders.

[25]  G. Salum,et al.  Psychometric properties of the dimensional anxiety scales for DSM‐5 in a Brazilian community sample , 2017, International journal of methods in psychiatric research.

[26]  C. Otte,et al.  Changes in cortisol secretion during antidepressive treatment and cognitive improvement in patients with major depression: A longitudinal study , 2011, Psychoneuroendocrinology.

[27]  Eric Vermetten,et al.  Hippocampal volume, memory, and cortisol status in major depressive disorder: effects of treatment , 2004, Biological Psychiatry.

[28]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[29]  J. Price,et al.  Machine learning approaches for integrating clinical and imaging features in late‐life depression classification and response prediction , 2015, International journal of geriatric psychiatry.

[30]  A. Simmons,et al.  Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. , 2011, Archives of general psychiatry.

[31]  J. Ashburner,et al.  Prognostic and Diagnostic Potential of the Structural Neuroanatomy of Depression , 2009, PloS one.

[32]  A. Hamm,et al.  Neurobiological markers predicting treatment response in anxiety disorders: A systematic review and implications for clinical application , 2016, Neuroscience & Biobehavioral Reviews.

[33]  Teruhiko Higuchi,et al.  Discrimination between schizophrenia and major depressive disorder by magnetic resonance imaging of the female brain. , 2013, Journal of psychiatric research.

[34]  H. Wittchen,et al.  Human and economic burden of generalized anxiety disorder , 2008, Depression and anxiety.

[35]  Clemens Kirschbaum,et al.  The scanner as a stressor: evidence from subjective and neuroendocrine stress parameters in the time course of a functional magnetic resonance imaging session. , 2011, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[36]  J. Hoyer,et al.  PSYCHOMETRIC PROPERTIES OF THE DIMENSIONAL ANXIETY SCALES FOR DSM‐V IN AN UNSELECTED SAMPLE OF GERMAN TREATMENT SEEKING PATIENTS , 2012, Depression and anxiety.

[37]  Christopher S. Monk,et al.  Common and distinct amygdala-function perturbations in depressed vs anxious adolescents. , 2009, Archives of general psychiatry.

[38]  J. Hirsch,et al.  Reduced Anterior Temporal and Hippocampal Functional Connectivity During Face Processing Discriminates Individuals with Social Anxiety Disorder from Healthy Controls and Panic Disorder, and Increases Following Treatment , 2014, Neuropsychopharmacology.

[39]  Jack L. Lancaster,et al.  The Talairach Daemon a database server for talairach atlas labels , 1997 .

[40]  J. Violanti,et al.  Area Under the Curve and Other Summary Indicators of Repeated Waking Cortisol Measurements , 2007, Psychosomatic medicine.

[41]  Janaina Mourão Miranda,et al.  PRoNTo: Pattern Recognition for Neuroimaging Toolbox , 2013, Neuroinformatics.

[42]  Ulrike Lueken,et al.  Neural structures, functioning and connectivity in Generalized Anxiety Disorder and interaction with neuroendocrine systems: a systematic review. , 2014, Journal of affective disorders.

[43]  J L Lancaster,et al.  Automated Talairach Atlas labels for functional brain mapping , 2000, Human brain mapping.

[44]  H. Wittchen,et al.  Diagnostic classification of specific phobia subtypes using structural MRI data: a machine-learning approach , 2014, Journal of Neural Transmission.

[45]  D. Pine,et al.  Incidence and risk patterns of anxiety and depressive disorders and categorization of generalized anxiety disorder. , 2010, Archives of general psychiatry.

[46]  S. Rauch,et al.  Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play , 2013, Molecular Psychiatry.

[47]  Joseph A Maldjian,et al.  Precentral gyrus discrepancy in electronic versions of the Talairach atlas , 2004, NeuroImage.

[48]  E. Bora,et al.  Gray matter abnormalities in Major Depressive Disorder: a meta-analysis of voxel based morphometry studies. , 2012, Journal of affective disorders.

[49]  C. Davatzikos,et al.  Neuroanatomical Classification in a Population-Based Sample of Psychotic Major Depression and Bipolar I Disorder with 1 Year of Diagnostic Stability , 2014, BioMed research international.

[50]  E. Bora,et al.  Meta-analysis of volumetric abnormalities in cortico-striatal-pallidal-thalamic circuits in major depressive disorder , 2011, Psychological Medicine.

[51]  C. Spielberger,et al.  Manual for the State-Trait Anxiety Inventory , 1970 .

[52]  Brian Patenaude,et al.  Neurobiological Signatures of Anxiety and Depression in Resting-State Functional Magnetic Resonance Imaging , 2015, Biological Psychiatry.

[53]  A. M. Ruscio,et al.  A meta-analysis of the relation of intolerance of uncertainty to symptoms of generalized anxiety disorder, major depressive disorder, and obsessive-compulsive disorder. , 2011, Clinical psychology review.

[54]  J. Talbott Prevalence of Generalized Anxiety Disorder in General Practice in Denmark, Finland, Norway, and SwedenMunk-Jørgensen P, Rasmussen I, Allgulander C, et al (Aarhus Univ Hosp, Aalborg, Denmark; Karolinska Institutet, Stockholm; Rikshospitalet-Radiumhospitalet Med Ctr, Oslo, Norway; et al) Psychiatric S , 2008 .

[55]  Axel Schäfer,et al.  Localized gray matter volume abnormalities in generalized anxiety disorder , 2011, European Archives of Psychiatry and Clinical Neuroscience.

[56]  John W. Williams,et al.  Does this patient have generalized anxiety or panic disorder?: The Rational Clinical Examination systematic review. , 2014, JAMA.

[57]  Andrew Simmons,et al.  Disorder-Specific Predictive Classification of Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) Relative to Autism Using Structural Magnetic Resonance Imaging , 2013, PloS one.

[58]  M. Katzman,et al.  Rates of detection of mood and anxiety disorders in primary care: a descriptive, cross-sectional study. , 2011, The primary care companion for CNS disorders.

[59]  P. Cowen,et al.  Increased salivary cortisol after waking in depression , 2005, Psychopharmacology.

[60]  C. Kirschbaum,et al.  Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change , 2003, Psychoneuroendocrinology.

[61]  S. Bernasconi,et al.  Neuroendocrine Responses to Psychological Stress in Adolescents with Anxiety Disorder , 2000, Neuropsychobiology.

[62]  Olga V. Demler,et al.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[63]  M. First,et al.  Structured clinical interview for DSM-IV axis I disorders : SCID-I: clinical version : administration booklet , 1996 .

[64]  Chien-Han Lai Gray matter volume in major depressive disorder: A meta-analysis of voxel-based morphometry studies , 2013, Psychiatry Research: Neuroimaging.

[65]  John Ashburner,et al.  A fast diffeomorphic image registration algorithm , 2007, NeuroImage.

[66]  Xiao-hong Ma,et al.  Analysis of hair cortisol level in first-episodic and recurrent female patients with depression compared to healthy controls. , 2015, Journal of affective disorders.

[67]  T. Suslow,et al.  Discriminating unipolar and bipolar depression by means of fMRI and pattern classification: a pilot study , 2013, European Archives of Psychiatry and Clinical Neuroscience.

[68]  Robert L. Spitzer,et al.  Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7. Copyright: American Medical Association. , 2006 .

[69]  N. Rose,et al.  Biomarkers in psychiatry , 2009, Nature.

[70]  D. Mohr,et al.  Depression and cortisol responses to psychological stress: A meta-analysis , 2005, Psychoneuroendocrinology.

[71]  R. Kessler,et al.  One‐year prevalence of subthreshold and threshold DSM‐IV generalized anxiety disorder in a nationally representative sample , 2001, Depression and anxiety.

[72]  H. Wittchen,et al.  Cost of anxiety disorders in Europe , 2005, European journal of neurology.

[73]  F. Zitman,et al.  Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. , 2009, Archives of general psychiatry.

[74]  C. Kirschbaum,et al.  Decreased hair cortisol concentrations in generalised anxiety disorder , 2011, Psychiatry Research.

[75]  M. Zimmerman,et al.  Pathological worry in depressed and anxious patients. , 2003, Journal of anxiety disorders.

[76]  Laura Manea,et al.  Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. , 2016, General hospital psychiatry.

[77]  Normand Carrey,et al.  Disorder-specific volumetric brain difference in adolescent major depressive disorder and bipolar depression , 2013, Brain Imaging and Behavior.

[78]  M. First,et al.  Structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version : scoresheet , 1997 .

[79]  H. Wittchen,et al.  Screening for anxiety disorders , 1998, British Journal of Psychiatry.

[80]  Gilles J. Guillemin,et al.  Expression of Tryptophan 2,3-Dioxygenase and Production of Kynurenine Pathway Metabolites in Triple Transgenic Mice and Human Alzheimer's Disease Brain , 2013, PloS one.

[81]  C. Reynolds,et al.  Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder , 2008, Psychoneuroendocrinology.

[82]  Masato Fukuda,et al.  Neuroimaging-aided differential diagnosis of the depressive state , 2014, NeuroImage.

[83]  B. Löwe,et al.  A brief measure for assessing generalized anxiety disorder: the GAD-7. , 2006, Archives of internal medicine.

[84]  Shitij Kapur,et al.  Biomarkers of treatment outcome in schizophrenia: Defining a benchmark for clinical significance , 2015, European Neuropsychopharmacology.

[85]  Luca Baldassarre,et al.  Localizing and Comparing Weight Maps Generated from Linear Kernel Machine Learning Models , 2013, 2013 International Workshop on Pattern Recognition in Neuroimaging.

[86]  P. Boksa,et al.  A way forward for research on biomarkers for psychiatric disorders. , 2013, Journal of psychiatry & neuroscience : JPN.

[87]  M. Filippi,et al.  Brain structural abnormalities in patients with major depression with or without generalized anxiety disorder comorbidity , 2015, Journal of Neurology.

[88]  Michael L. Johnson,et al.  Generalized Anxiety Disorder in Older Medical Patients: Diagnostic Recognition, Mental Health Management and Service Utilization , 2009, Journal of Clinical Psychology in Medical Settings.

[89]  A. Etkin,et al.  Common abnormalities and disorder-specific compensation during implicit regulation of emotional processing in generalized anxiety and major depressive disorders. , 2011, The American journal of psychiatry.

[90]  R. Kessler,et al.  Twelve‐month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States , 2012, International journal of methods in psychiatric research.

[91]  B. Penninx,et al.  Hair cortisol, stress exposure, and mental health in humans: A systematic review , 2013, Psychoneuroendocrinology.

[92]  H. Wittchen,et al.  Prevalence of generalized anxiety disorder in general practice in Denmark, Finland, Norway, and Sweden. , 2006, Psychiatric services.

[93]  N. Tzourio-Mazoyer,et al.  Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain , 2002, NeuroImage.